Focus: Medtech


Chart of the complexities involved in getting today’s medtech products on the market


are made. Soſt ware architecture, verifi cation results, risk management and cybersecurity documentation all originate from engineering activities. When these elements are developed and documented in parallel with design, preparing for submission becomes more structured and predictable.


An integrated perspective Across all of these areas a consistent theme emerges. T e most eff ective development environments are those where design, risk, quality, regulatory compliance and performance are connected rather than managed in isolation. Over time, this has led to a shiſt in


how teams approach both services and systems. At MethodSense, this integration has been central to how quality and regulatory strategy has been executed during the past 26 years, with close


Energy


consumption, system effi ciency and component lifecycle


management must be


integrated into design decisions from the outset


collaboration across all contributors to innovation. T is same approach is refl ected in the regulatory compliance platform, LuminLogic. It integrates AI-enabled intelligence that’s grounded in practical experience and traceability. T e platform is designed to bring together all stakeholders and support decision making from design through to commercialisation. For embedded system developers,


this creates an opportunity. When engineering decisions are made within a connected system, they become easier to support and adapt, and more aligned with how regulators evaluate devices. Following this approach, successful medtech products are not only innovative but are built in a way that consistently demonstrates safety, performance and regulatory compliance from the earliest stages of design.


www.electronicsworld.co.uk June 2026 09


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44